Aims While data from randomized trials suggest a declining incidence of sudden cardiac
death (SCD) among heart failure patients, the extent to which such a trend is present among …

Background Although cardiac resynchronization therapy (CRT) is effective for some patients
with heart failure and a reduced left ventricular ejection fraction (HFrEF), evidence gaps …

Cardiac implantable electronic devices (CIED) are potentially life-saving treatments for
several cardiac conditions, but are not without risk. Despite dissemination of recommended …

Aims The very long-term outcome of patients who survive the first few years after receiving
cardiac resynchronization therapy (CRT) has not been well described thus far. We aimed to …

Aims The decision to implant a cardiac resynchronization therapy pacemaker (CRT-P) or a
cardiac resynchronization therapy defibrillator (CRT-D) may be challenging. There are no …

Objectives: This study sought to compare sex difference for procedural aspects and
complications in the European Society of Cardiology CRT Survey II, exploring whether …

Background Current guidelines did not provide recommendations on indications of an
additional implantable cardioverter‐defibrillator (ICD) to patients receiving cardiac …

Background There is limited evidence on the influence of sex on the decision to implant a
cardiac resynchronization therapy device with pacemaker (CRT-P) or defibrillator (CRT-D) …

Cardiac resynchronization therapy (CRT) has rapidly evolved as a standard therapy for
heart failure (HF) patients with ventricular conduction delay. Although in early trials, only …

Background The implantation rates of cardiac implantable electronic devices have steadily
increased, accompanied by a steeper rise of device related infections (DRI). Hypothesis The …